Scientists find how to prevent or treat lung damage in long COVID
A team of researchers at Stanford University, led by Dr. Peter Cheng and Dr. Purvesh Khatri, along with a colleague from Taiwan have made...
Bivalent boosters block severe COVID-19
COVID-19 vaccines have saved many lives. The original vaccines were released in late 2020. They targeted the initial strain of SARS-CoV-2, the virus that...
Why people with long COVID have “brain fog”
Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), is a condition where individuals experience persistent symptoms after recovering from COVID-19, lasting...
This type of vaccine can provide better protection against COVID
In a study from UNSW's Kirby institute and elsewhere, scientists found newer variant-specific bivalent vaccines offer on average 1.6 times better immunity against COVID-19...
Long COVID linked to cognitive and mental problems, study shows
Long COVID is associated with reduced brain oxygen levels, worse performance on cognitive tests, and increased psychiatric symptoms such as depression and anxiety.
We can learn a lot about long COVID from years of diagnosing and treating...
Long COVID reportedly affects about 10% of post-COVID patients, and describes a range of ongoing or new symptoms three months post-infection.
Given the COVID pandemic...
Much has been learned about long COVID – and much remains to be learned
This much researchers agree upon: Long COVID is a serious and sometimes debilitating condition that can strike previously healthy people after even mild bouts...
Three in five long COVID patients have organ damage a year after infection
The latest data from the Office for National Statistics suggests that more than 1.2 million people in the UK report living with long COVID...
While home recovering from COVID-19, she saved her husband’s life
One day last July, Mike Button settled into his home office, ready to start catching up on the backlog of things that had accumulated...
Common diabetes drug linked to less severe COVID-19
Scientists examined adults with type 2 diabetes who were taking metformin, a commonly prescribed diabetes medication.